List of Intermediates
With years of knowledge and multiple export licenses and certificates – Aptra Synthesis offers a portfolio of products including 100+ API’s, Pellets, Direct Compression, Excipients.
Learn more about our capabilities by downloading our brochure.
Chemical Name
2-(4-(2-hydroxyethyl)phenyI)-2-Methylpropanoic acid
CAS No.
552301—45—8
End Use
Bilastin
(R)-4-PropyIdihydrofuran-2(3H)-one
63095—51—2
Brivaracetam
2-(4-Cyano phenyl amino) acetic acid
42288—26—6
Dabigatran
4-(methyIamino)-3-nitrobenzoic acid
41263—74—5
Dabigatran
4-Amino Benzonitrile
873—74—5
Dabigatran
Ethyl 3-(Pyridin-2yl amino) Propionate
103041—38—9
Dabigatran
Ethyl -3[3-Amino-4-methyl amino)-N(2-PyridyI) benzamide] propanoate
212322—56—0
Dabigatran
Ethyl-3(2-(t(4-cyanophenyI) amino) methyl)-1-methyl-n-(pyridine-2-yI) 1H-Benzo[D] imidazoIe-5-carboxamido) propanoate
211915—84—3
Dabigatran
Ethyl-3-(4-(methyIamino)-3-Nitro-N-(Pyridin-2-yI)benzamide) propanoate
429659—01—8
Dabigatran
2-ChIoro-1,3-bis(dimethyIamino)trimethinium hexafluorophosphate
291756—76—8
Etoricoxib
4- Methyl sulphonyl phenyl acetic acid
90536—66—6
Etoricoxib
Ketosulfone
221615—75—4
Etoricoxib
Chemical Name
Methyl-6-methyInicotinate
CAS No.
5470-70-2
End Use
Etoricoxib
3-[2-(3-ChIorophenyI)ethyI]-2-pyridinecarbonitriIe
31255—57—9
Loratadine
N-methyl loratadine
38092—89—6
Loratadine
(2,4,5-trifIuorophenyI)acetic acid
209995—38—0
Sitagliptin
(3R)-3-Amino-1-[3-(trifIuoromethyI)-5,6,7,8-tetrahydro-1,2,4-triazoIo [4,3-a]pyrazin-7-yI]-4-(2,4,5-trifIuorophenyI)butan-1-one
486460—32—6
Sitagliptin
2,4,5-TrifIuoro-§-oxo-benzenebutanoic Acid Methyl Ester
769195—26—8
Sitagliptin
3—(Trifluoromethyl)—5,6,7,8—tetrahydro—[1,2,4]triazoIo[4,3-a]pyrazine Hydrochloride
762240—92—6
Sitagliptin
Sitagliptin keto amide
764667—65—4
Sitagliptin
1-(7,8-Dinitro-1,2,4,5-tetrahydro-3H-1,5-methanobenzo[d] azepin-3-yI)ethan-1-one
1213782—02—5
Varenicline
N-methyl-4-ChIoropiperidine
5570—77—4
Loratadine
| Chemical Name | CAS No. | End Use |
|---|---|---|
| 2-(4-(2-hydroxyethyl)phenyI)-2-Methylpropanoic acid | 552301—45—8 | Bilastin |
| (S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride. | 141109-19-5 | Clopidogrel Bisulphate |
| (R)-4-PropyIdihydrofuran-2(3H)-one | 63095—51—2 | Brivaracetam |
| 2-(4-Cyano phenyl amino) acetic acid | 42288—26—6 | Dabigatran |
| 4-(methyIamino)-3-nitrobenzoic acid | 41263—74—5 | Dabigatran |
| 4-Amino Benzonitrile | 873—74—5 | Dabigatran |
| Ethyl 3-(Pyridin-2yl amino) Propionate | 103041—38—9 | Dabigatran |
| Ethyl -3[3-Amino-4-methyl amino)-N(2-PyridyI) benzamide] propanoate | 212322—56—0 | Dabigatran |
| Ethyl-3(2-(t(4-cyanophenyI) amino) methyl)-1-methyl-n-(pyridine-2-yI) 1H-Benzo[D] imidazoIe-5-carboxamido) propanoate | 211915—84—3 | Dabigatran |
| Ethyl-3-(4-(methyIamino)-3-Nitro-N-(Pyridin-2-yI)benzamide) propanoate | 429659—01—8 | Dabigatran |
| 2-ChIoro-1,3-bis(dimethyIamino)trimethinium hexafluorophosphate | 291756—76—8 | Etoricoxib |
| 4- Methyl sulphonyl phenyl acetic acid | 90536—66—6 | Etoricoxib |
| Ketosulfone | 221615—75—4 | Etoricoxib |
| Methyl-6-methyInicotinate | 5470-70-2 | Etoricoxib |
| 3-[2-(3-ChIorophenyI)ethyI]-2-pyridinecarbonitriIe | 31255—57—9 | Loratadine |
| N-methyl loratadine | 38092—89—6 | Loratadine |
| (2,4,5-trifIuorophenyI)acetic acid | 209995—38—0 | Sitagliptin |
| (3R)-3-Amino-1-[3-(trifIuoromethyI)-5,6,7,8-tetrahydro-1,2,4-triazoIo [4,3-a]pyrazin-7-yI]-4-(2,4,5-trifIuorophenyI)butan-1-one | 486460—32—6 | Sitagliptin |
| 2,4,5-TrifIuoro-§-oxo-benzenebutanoic Acid Methyl Ester | 769195—26—8 | Sitagliptin |
| 3—(Trifluoromethyl)—5,6,7,8—tetrahydro—[1,2,4]triazoIo[4,3-a]pyrazine Hydrochloride | 762240—92—6 | Sitagliptin |
| Sitagliptin keto amide | 764667—65—4 | Sitagliptin |
| 1-(7,8-Dinitro-1,2,4,5-tetrahydro-3H-1,5-methanobenzo[d] azepin-3-yI)ethan-1-one | 1213782—02—5 | Varenicline |
| N-methyl-4-ChIoropiperidine | 5570—77—4 | Loratadine |
Disclaimer
No information in this catalog – including any reference to any product or service – constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.